Cognition Therapeutics, Inc. Share Price

NASDAQ: CGTX

Small Cap

$1.47

(+-0.34%)

as on September 19, 2025 at 1:29 am IST

$₹

Cognition Therapeutics, Inc. Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$1.45
Day's Price Range
$1.54
$1.47
1.36%
Downside
4.76%
Upside
52 Week's Low
52 Week's High
$0.22
52-Week Price Range
$3.83
$1.47
84.88%
Downside
160.54%
Upside

Cognition Therapeutics, Inc. share price movements today

Previous Close: $1.47
Open: $1.48
Volume: 1.9M
Day's Low - High: $1.45 - $1.54
52 Week Low - High: $0.22 - $3.83

Cognition Therapeutics, Inc. Historical Returns

1 Month Return: -1.34 %
3 Month Return: + 425 %
1 Year Return: + 145.37 %
3 Year Return: -16 %
5 Year Return: 0 %

Cognition Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Cognition Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$142.0M

EPS (TTM)

-0.4025

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-52.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Cognition Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cognition Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cognition Therapeutics, Inc.	BUY	$142.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Cognition Therapeutics, Inc. Stock including INR - Dollar returns

The Cognition Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Cognition Therapeutics, Inc. investment value today

Current value as on today

₹2,49,953

Returns

₹1,49,953

(+149.95%)

Returns from Cognition Therapeutics, Inc. Stock

₹1,45,000 (+145%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Cognition Therapeutics, Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Cognition Therapeutics, Inc.. Average target price of $3.25

Cognition Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Cognition Therapeutics, Inc..

What analysts predicted

54.77%UPSIDE

Target Price

$3.25

Current Price

$1.47

Analyzed by

9 Analysts

Target

$3.25

Cognition Therapeutics, Inc. target price $3.25, a slight upside of 54.77% compared to current price of $1.47. According to 9 analysts rating.

Cognition Therapeutics, Inc. Stock's Interest Amongst Investors

Investment in Cognition Therapeutics, Inc. Shares on INDmoney has grown by 195.50% over the past 30 days, indicating increased transactional activity.

Time period: August 20, 2025 to September 19, 2025

Change:195.50% versus previous 30 day period

Search interest for Cognition Therapeutics, Inc. Stock has increased by 294% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:294% versus previous 30 day period

Cognition Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-8	-11	-14	-15	-14	-14	-14	-10	-13	-13
EBITDA	-6	-4	-6	-8	-9	-6	-9	-7	-13	-13
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-4	-6	-8	-9	-7	-9	-7	-8	-6
Income Tax Expense	-2	0	0	2	0	-	-	-	-	-
Net Income	-3	-4	-6	-8	-9	-7	-9	-7	-8	-6
Net Profit Margin	0.00%	0.00%	0.00%	-2188.44%	0.00%	0.00%	0.00%	-3136.80%	0.00%	0.00%

Cognition Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0
Operating Income	-17	-17	-28	-43	-50	-53
EBITDA	-3	-5	-10	-21	-25	-33
Interest Expense	1	1	0	0	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-4	-7	-11	-21	-25	-33
Income Tax Expense	2	2	-1	-22	-	-
Net Income	-6	-10	-10	0	-25	-33
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cognition Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-6	-8	-9	-7	-9	-7	-8	-6
Operating Cash Flow	-3	-4	-5	-7	-5	-6	-8	-9	-5
Investing Cash Flow	0	0	0	-	0	-	0	-	-
Financing Cash Flow	2	0	2	11	0	0	11	1	0
Change in Cash	-1	-4	-3	4	-6	-6	2	-8	-4

Cognition Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-11	-21	-25	-33
Operating Cash Flow	-3	-3	-18	-16	-28
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	5	53	5	4	23
Change in Cash	2	49	-13	-11	-4

Global Institutional Holdings in Cognition Therapeutics, Inc.

Funds	Holdings
BIOS CAPITAL MANAGEMENT, LP	9.68%
Vanguard Group Inc	2%
Acadian Asset Management LLC	1.63%
Voss Capital LLC	0.73%
CM Management, LLC	0.65%

See all

Insights on Cognition Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CGTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, CGTX stock has moved up by 425.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 127.5%

About Cognition Therapeutics, Inc.

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.

Organisation	Cognition Therapeutics, Inc.
Headquarters	2500 Westchester Ave., Purchase, NY, United States, 10577
Industry	Services
CEO	Ms. Lisa Ricciardi
E-voting on shares	Click here to vote

Key Management of Cognition Therapeutics, Inc.

Name	Title
Mr. John Brendan Doyle	Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.	Chief Medical Officer and Head of R&D
Dr. Steven A. Weissman Ph.D.	VP & Head of CMC
Ms. Anita Cornet	Head of Quality
Mr. Bobby Horn	Corporate Controller
Ms. Lisa Ricciardi	CEO, President & Director

FAQs

What is Cognition Therapeutics, Inc. share price today?

Cognition Therapeutics, Inc. share price today is $1.47 as on September 19, 2025 at 1:29 am IST at the close of the market. Cognition Therapeutics, Inc. share today touched a day high of $1.54 and a low of $1.45.

What is the 52 week high and 52 week low for Cognition Therapeutics, Inc. share?

Cognition Therapeutics, Inc. share touched a 52 week high of $3.83 on August 25, 2025 and a 52 week low of $0.22 on May 28, 2025. Cognition Therapeutics, Inc. stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $1.47,which is 61.62% down from its 52 week high and 561.27% up from its 52 week low.

What is Cognition Therapeutics, Inc.'s market capitalisation today?

Cognition Therapeutics, Inc. market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Cognition Therapeutics, Inc. Stock (CGTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cognition Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cognition Therapeutics, Inc. Shares that will get you 1.0204 shares as per Cognition Therapeutics, Inc. share price of $1.47 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cognition Therapeutics, Inc. Stock (CGTX) from India?

Indian investors can start investing in Cognition Therapeutics, Inc. (CGTX) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 4:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Cognition Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 4:40 am IST). Based on Cognition Therapeutics, Inc. share’s latest price of $1.47 as on September 19, 2025 at 1:29 am IST, you will get 6.8027 shares of Cognition Therapeutics, Inc.. Learn more about fractional shares .